UK markets closed
  • NIKKEI 225

    27,588.37
    +66.11 (+0.24%)
     
  • HANG SENG

    24,656.46
    -309.09 (-1.24%)
     
  • CRUDE OIL

    84.08
    +0.77 (+0.92%)
     
  • GOLD FUTURES

    1,843.50
    +1.80 (+0.10%)
     
  • DOW

    34,364.50
    +99.13 (+0.29%)
     
  • BTC-GBP

    26,978.26
    +572.44 (+2.17%)
     
  • CMC Crypto 200

    839.82
    +29.22 (+3.60%)
     
  • ^IXIC

    13,855.13
    +86.21 (+0.63%)
     
  • ^FTAS

    4,099.16
    -118.15 (-2.80%)
     

Magellan Health Announces Two New Appointments to Magellan Health Studio Advisory Council

·3-min read

PHOENIX, November 12, 2021--(BUSINESS WIRE)--Magellan Health, Inc. (NASDAQ: MGLN) today announced two new healthcare experts have been appointed to serve on the Magellan Health Studio Advisory Council. The Council consists of leaders who bring their unique perspectives to Magellan as it reinvents the health and wellbeing experience for customers and members through the design and development of integrated, whole person solutions.

The newly appointed members are Dr. Andrey Ostrovsky, managing partner, Social Innovation Ventures, and Dr. Harold Pincus, professor and vice chair of the Department of Psychiatry and co-director of the Irving Institute for Clinical and Translational Research, Columbia University.

"Dr. Ostrovsky and Dr. Pincus are both well-qualified and highly regarded experts, and we look forward to their contributions to the Magellan Health Studio Advisory Council," said Alisa Bahl, Ph.D., chief strategy and innovation officer, Magellan Healthcare.

Brief biographies of the new Council members follow:

Dr. Ostrovsky was the former chief medical officer of the U.S. Medicaid program and is currently the managing partner at Social Innovation Ventures, where he invests in and advises companies and non-profits dedicated to eliminating disparities. He also advises federal and state regulators on how to incorporate human centered design into policy making. He previously operated a series of methadone clinics in Baltimore, Maryland. Prior to working on the front line of the opioid use disorder crisis, he served as the chief medical officer for the Center for Medicaid and CHIP Services. Dr. Ostrovsky holds a medical doctorate and undergraduate degrees in Chemistry and Psychology magna cum laude from Boston University and is a member of Phi Beta Kappa. He completed his pediatrics residency training in the Boston Combined Residency Program at Boston Medical Center and Boston Children’s Hospital where he was a clinical instructor at Harvard Medical School. He is currently teaching faculty and attending physician at Children’s National Medical Center.

Dr. Pincus is professor and vice chair of the Department of Psychiatry and co-director of the Irving Institute for Clinical and Translational Research at Columbia University. Dr. Pincus also serves as a senior scientist at the RAND Corporation. He is also the national director of the Health and Aging Policy Fellowship (supported by The John A. Hartford Foundation, West Health Institute and Atlantic Philanthropies) and previously directed national programs for the Robert Wood Johnson and MacArthur Foundations. Dr. Pincus has been appointed to the editorial boards of 12 scientific journals and published over 500 scientific publications in health services research, science policy, research career development, quality of care and the diagnosis, classification, and treatment of mental disorders. Dr. Pincus is the 2017 recipient of the C. Charles Burlingame Award by the Institute of Living for contributions to the field of psychiatry and has received the Menninger Award from the American College of Physicians, Research Mentorship Award from the American Association of Chairs of Departments of Psychiatry and APA, Vestermark Award from NIMH and APA, among other honors.

The Magellan Health Studio was launched in 2020 to accelerate the design, development and delivery of integrated solutions for employers, health plans, healthcare systems, providers and ultimately members. Magellan Health Studio conducts human-centered research, explores creative solutions, and engages with key partners to develop and test solutions to improve engagement, health outcomes, and performance.

About Magellan Health: Magellan Health, Inc., is a leader in managing the fastest growing, most complex areas of health, including special populations, complete pharmacy benefits and other specialty areas of healthcare. Magellan supports innovative ways of accessing better health through technology, while remaining focused on the critical personal relationships that are necessary to achieve a healthy, vibrant life. Magellan's customers include health plans and other managed care organizations, employers, labor unions, various military and governmental agencies and third-party administrators. For more information, visit MagellanHealth.com.

(MGLN-GEN)

View source version on businesswire.com: https://www.businesswire.com/news/home/20211112005322/en/

Contacts

Media: Lilly Ackley, ackleyl@magellanhealth.com, (860) 507-1923
Investors: Darren Lehrich, lehrichd@magellanhealth.com, (860) 507-1814

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting